Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Steegmaier
M. Steegmaier
Polo-like kinase
Cancer research
Biology
Regulator
Pathology
4
Papers
65
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I study of two administration schedules of the Polo-like kinase 1 inhibitor BI 2536 in patients with advanced solid tumors
2006
Journal of Clinical Oncology
Gerd Munzert
S. Steinbild
A. Frost
S. Hedborn
Jochen Rentschler
Rolf Kaiser
Dirk Trommeshauser
M. Hoffmann
M. Steegmaier
K. Mross
Show All
Source
Cite
Save
Citations (17)
A phase I repeated dose escalation study of the Polo-like kinase 1 inhibitor BI 2536 in patients with advanced solid tumours
2006
Ralf-Dieter Hofheinz
Andreas Hochhaus
Salah-Eddin Al-Batran
A. Nanci
V. Reichardt
Dirk Trommeshauser
M. Hoffmann
M. Steegmaier
Gerd Munzert
Elke Jäger
Show All
Source
Cite
Save
Citations (16)
A phase I repeated dose escalation study of the Polo-like kinase 1 inhibitor BI 2536 in patients with advanced solid tumours
2006
Journal of Clinical Oncology
Ralf-Dieter Hofheinz
Andreas Hochhaus
Salah-Eddin Al-Batran
A. Nanci
V. Reichardt
Dirk Trommeshauser
M. Hoffmann
M. Steegmaier
Gerd Munzert
Elke Jäger
Show All
Source
Cite
Save
Citations (17)
A phase I study of two administration schedules of the Polo-like kinase 1 inhibitor BI 2536 in patients with advanced solid tumors
2006
Gerd Munzert
S. Steinbild
Annette Frost
S. Hedborn
Jochen Rentschler
Rolf Kaiser
Dirk Trommeshauser
M. Hoffmann
M. Steegmaier
Klaus Mross
Show All
Source
Cite
Save
Citations (15)
1